These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34098976)

  • 21. Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.
    Niehues T; Horneff G; Michels H; Höck MS; Schuchmann L; ;
    Rheumatol Int; 2005 Apr; 25(3):169-78. PubMed ID: 15688190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases.
    Vergidis P; Avery RK; Wheat LJ; Dotson JL; Assi MA; Antoun SA; Hamoud KA; Burdette SD; Freifeld AG; McKinsey DS; Money ME; Myint T; Andes DR; Hoey CA; Kaul DA; Dickter JK; Liebers DE; Miller RA; Muth WE; Prakash V; Steiner FT; Walker RC; Hage CA
    Clin Infect Dis; 2015 Aug; 61(3):409-17. PubMed ID: 25870331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Juvenile Idiopathic Arthritis.
    Barut K; Adrovic A; Şahin S; Kasapçopur Ö
    Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.
    Birolo C; Zannin ME; Arsenyeva S; Cimaz R; Miserocchi E; Dubko M; Deslandre CJ; Falcini F; Alessio M; La Torre F; Denisova E; Martini G; Nikishina I; Zulian F
    J Rheumatol; 2016 Nov; 43(11):2068-2073. PubMed ID: 27633826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
    Roubille C; Haraoui B
    Semin Arthritis Rheum; 2014 Apr; 43(5):613-26. PubMed ID: 24231065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.
    Trindade VC; Carneiro-Sampaio M; Bonfa E; Silva CA
    Paediatr Drugs; 2021 Jul; 23(4):331-347. PubMed ID: 34244988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Case of Disseminated Histoplasmosis in a Patient with Rheumatoid Arthritis on Abatacept.
    Jain N; Doyon JB; Lazarus JE; Schaefer IM; Johncilla ME; Agoston AT; Dalal AK; Velásquez GE
    J Gen Intern Med; 2018 May; 33(5):769-772. PubMed ID: 29532302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort.
    Said MA; Silva LSTE; de Oliveira Rocha AM; Alves GGB; Piotto DGP; Len CA; Terreri MT
    Adv Rheumatol; 2020 Nov; 60(1):53. PubMed ID: 33153496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unusual manifestation of histoplasmosis in connective tissue diseases.
    Ceccato F; Gongora V; Zunino A; Roverano S; Paira S
    Clin Rheumatol; 2007 Oct; 26(10):1717-9. PubMed ID: 17541496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Disease-modifying treatment for inflammatory rheumatism in sub-Saharan Africa: outcome at 6 months of 205 Senegalese patients with rheumatoid arthritis].
    Ndongo S; Pouye A; Lekpa FK; Bihéhé DM; Tiendrebeogo J; Ndao AC; Ka MM; Moreira Diop T
    Med Sante Trop; 2012; 22(4):385-9. PubMed ID: 23352953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncharted waters: mesenchymal stem cell treatment for pediatric refractory rheumatic diseases; a single center case series.
    Wong SC; Medrano LC; Hoftman AD; Jones OY; McCurdy DK
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):87. PubMed ID: 34112214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
    Jansson-Knodell CL; Harris CE; Loftus EV; Walker RC; Enzler MJ; Virk A
    Dig Dis Sci; 2021 Jan; 66(1):190-198. PubMed ID: 32144603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    Tappeiner C; Mesquida M; Adán A; Anton J; Ramanan AV; Carreno E; Mackensen F; Kotaniemi K; de Boer JH; Bou R; de Vicuña CG; Heiligenhaus A
    J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis.
    Tappeiner C; Miserocchi E; Bodaghi B; Kotaniemi K; Mackensen F; Gerloni V; Quartier P; Lutz T; Heiligenhaus A
    J Rheumatol; 2015 Apr; 42(4):706-11. PubMed ID: 25641892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Children with Juvenile Idiopathic Arthritis.
    Viswanathan V; Murray KJ
    Indian J Pediatr; 2016 Jan; 83(1):63-70. PubMed ID: 26639461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abatacept in difficult-to-treat juvenile idiopathic arthritis.
    Kuemmerle-Deschner JB; Benseler S
    Biologics; 2008 Dec; 2(4):865-74. PubMed ID: 19707464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis.
    Brunner HI; Wong R; Nys M; Kou TD; Dominique A; Martini A; Lovell DJ; Ruperto N;
    Paediatr Drugs; 2020 Dec; 22(6):653-672. PubMed ID: 33029724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis.
    Buckley F; Finckh A; Huizinga TW; Dejonckheere F; Jansen JP
    J Manag Care Spec Pharm; 2015 May; 21(5):409-23. PubMed ID: 25943002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis.
    Cummins L; Katikireddi VS; Shankaranarayana S; Su KY; Duggan E; Videm V; Pahau H; Thomas R
    Intern Med J; 2015 Dec; 45(12):1266-73. PubMed ID: 26384029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.
    Spencer CH; Rouster-Stevens K; Gewanter H; Syverson G; Modica R; Schmidt K; Emery H; Wallace C; Grevich S; Nanda K; Zhao YD; Shenoi S; Tarvin S; Hong S; Lindsley C; Weiss JE; Passo M; Ede K; Brown A; Ardalan K; Bernal W; Stoll ML; Lang B; Carrasco R; Agaiar C; Feller L; Bukulmez H; Vehe R; Kim H; Schmeling H; Gerstbacher D; Hoeltzel M; Eberhard B; Sundel R; Kim S; Huber AM; Patwardhan A;
    Pediatr Rheumatol Online J; 2017 Jun; 15(1):50. PubMed ID: 28610606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.